DALLAS — The American Heart Association’s scientific sessions this week delivered a blunt message about vaping’s toll on the body. It is not a sledgehammer like a cigarette. It is a jackhammer.
Low-grade. Constant.
Still damage. Researchers presented evidence that e-cigarette chemicals do not just float harmlessly in vapor. They get into the bloodstream.
They inflame the endothelial cells that line arteries. Those cells stop relaxing properly.
That is a direct path to stiff arteries and rising blood pressure. Over time, that wears the heart down. The data is specific.
Diacetyl — the buttery flavoring that once sickened popcorn factory workers — shows up in users’ blood. So does acrolein, a breakdown product of propylene glycol. Both are known tissue-damaging agents.
Neither belongs circulating through a human cardiovascular system. One study tracked young adults who vape regularly.
Their bodies showed elevated oxidative stress and adrenaline-like compounds compared to non-users. That means they are operating in a constant state of fight or flight. The heart muscle does not rest.
It does not recover. It just keeps taking the hit.
Dr. Rose Marie Robertson, the AHA’s deputy chief science and medical officer, put it plainly. The cardiovascular effects are not subtle. That is a direct statement from the organization’s leadership.
No hedging. No call for more study. The evidence is already on the table.
What comes next is the hard part. Millions of Americans already use these devices.
Many started because they believed vaping was harmless — or at least safer than smoking. The new science says otherwise. The question now is what public health officials do with that knowledge.
Regulators have been slow to act on flavor bans and marketing restrictions. The AHA’s sessions put the biological mechanisms in plain view.
The chemicals cause inflammation. Inflammation drives arterial damage. That damage accumulates.
The risk is not theoretical. It is measurable. It is happening in young adults who never smoked a cigarette.
They are trading one set of harms for another. The trade may not be equal — cigarettes kill half their long-term users — but it is not zero.
The heart does not distinguish between smoke and vapor. It only knows what hits its tissue. Prevention is the obvious goal.
But prevention requires people to stop using the product. That means effective cessation programs for e-cigarettes.
Those programs barely exist. Most smoking-cessation resources were designed for combustible tobacco. Vaping is different.
The addiction profile is different. The withdrawal is different. The tools need to be different too.
The AHA’s sessions did not offer a solution. They offered a warning.
The chemicals are in the blood. The cells are inflamed. The heart is working harder.
That is the situation as it stands. What happens next depends on whether anyone acts on the data.
{“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Vaping Chemicals Inflame Arterial Cells, Heart Researchers Report”, “description”: “DALLAS — The American Heart Association’s scientific sessions this week delivered a blunt message about vaping’s toll on the body. It is not a sledgehammer…”, “datePublished”: “2026-06-29T07:10:00+00:00T09:30:00+00:00”, “author”: {“@type”: “Person”, “name”: “Ava Anderson”}, “publisher”: {“@type”: “Organization”, “name”: “InfoPulse Today”, “url”: “https://newsfeed.infopulsetoday.com/”}}
